The Prevalence of Metabolic Syndrome of Patients on Treatment with Haloperidol and Risperidone or Olanzapine
Velumani Suresh, J. D. Lakhani, Rakesh Shah, Lakhan Kataria & Ramachandran Balaraman · Journal of Pharmaceutical Research International · 2021
Background: The background of the work stems from the observation due to the prevalence of antipsychotic drugs in causing metabolic disorder. The metabolic disorder is one of the major concern of antipsychotic drugs for schizophrenic patients. The present study is mainly aimed to...
Open access
Research Article
10.9734/jpri/2021/v33i44A32618